Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors

NCT05952687 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Drug withdrawn by company.

Conditions

Rhabdoid Tumor
Atypical Teratoid/Rhabdoid Tumor
Atypical Teratoid/Rhabdoid Tumor of CNS
CNS Tumor

Interventions

DRUG: Idasanutlin
DRUG: Idasanutlin
DRUG: Selinexor

Sponsor

St. Jude Children's Research Hospital